Clinical Trial Update: Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a single-vial ID93 + GLA-SE vaccine in healthy adults completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• ID93 + GLA-SE

Snippet

Sponsor: Access to Advanced Health Institute (AAHI) | Conditions: Pulmonary TB | Phase 1 | Status: COMPLETED | Results posted: 2023-06-01